Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARIPRAZINE vs CASIMERSEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARIPRAZINE vs CASIMERSEN: Safety Overview

Metric CARIPRAZINE CASIMERSEN
Total FAERS Reports 6,547 767
Deaths Reported 194 7
Death Rate 3.0% 0.9%
Hospitalizations 702 87
Average Patient Age 40.4 yrs 14.0 yrs
% Female Patients 64.0% 0.4%
FDA Approval Date Dec 16, 2025 Feb 25, 2021
Manufacturer Allergan, Inc. Sarepta Therapeutics, Inc.
Route ORAL N/A
Marketing Status Prescription Prescription